International
The Morning Science

What science found today

‹
 

Research

Antibody-drug conjugate shows promising early results in Phase I trial in sarcoma patients

Medical Xpress ·

Antibody-drug conjugate shows promising early results in Phase I trial in sarcoma patients

The Brief

  • An antibody-drug conjugate showed promising early results in a Phase I trial in patients with soft tissue sarcoma.
  • The results were seen across several types of soft tissue sarcoma.
  • The findings were presented at the 38th EORTC-NCI-AACR Symposium.

Why it matters

Phase I trials mainly test safety and dosing, so these early signals suggest the approach may be worth pursuing in sarcoma, but efficacy is not yet established.

Who’s affected

  • sarcoma patients
  • oncologists and cancer researchers

An antibody-drug conjugate, a type of drug that targets and enters cancer cells like a Trojan Horse, has shown promising early results across diverse types of soft tissue sarcoma in a Phase I trial. The findings were presented at the 38th EORTC-NCI-AACR Symposium on Molecular…

How do you feel about this?

0 Comments

    Antibody-drug conjugate shows promising early results in Phase I trial in sarcoma patients – The Morning Science